Semnur Pharmaceuticals, Inc. Shareholders' Equity
Semnur Pharmaceuticals, Inc. (SMNR) had Shareholders' Equity of -$29.67 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-10
- 2026-06-30: Stockholders' Equity Attributable to Parent -$29.67M.
- 2026-03-31: Stockholders' Equity Attributable to Parent -$25.33M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$20.75M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$14.59M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | -$29.67M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | -$25.33M 10-Q · filed 2026-08-10 | |
| 2025-12-31 | -$20.75M 10-Q · filed 2026-08-10 | |
| 2025-09-30 | -$14.59M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | -$44.45M 10-Q · filed 2026-08-10 | -$11.14M 10-Q · filed 2025-08-15 |
| 2025-03-31 | -$43.45M 10-Q · filed 2026-08-10 | -$10.74M 10-Q · filed 2025-05-16 |
| 2024-12-31 | -$42.78M 10-Q · filed 2026-08-10 | -$10.42M 10-K · filed 2025-04-02 |
| 2024-09-30 | -$42.01M 10-Q · filed 2025-11-12 | -$9.45M 10-Q · filed 2024-11-19 |
| 2024-06-30 | -$40.71M 10-Q · filed 2025-11-12 | -$9.16M 10-Q · filed 2024-08-19 |
| 2024-03-31 | -$39.60M 10-Q · filed 2025-11-12 | -$8.82M 10-Q · filed 2024-05-22 |
| 2023-12-31 | -$38.09M S-1 · filed 2026-05-12 | -$8.28M 10-K · filed 2024-04-01 |
| 2023-09-30 | -$7.93M 10-Q · filed 2024-11-19 | |
| 2023-06-30 | -$6.59M 10-Q · filed 2024-11-19 | |
| 2023-03-31 | -$5.19M 10-Q · filed 2024-11-19 | |
| 2022-12-31 | -$3.27M 10-K · filed 2025-04-02 | |
| 2022-09-30 | -$1.86M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | -$1.67M 10-Q · filed 2023-11-09 | |
| 2022-03-31 | $13.66K 10-Q · filed 2023-11-09 | |
| 2022-01-04 | $0.00 10-Q · filed 2023-05-15 |